154
Participants
Start Date
December 10, 2020
Primary Completion Date
April 12, 2022
Study Completion Date
April 7, 2024
Recombinant human Neuregulin for injection
10 hours per day i.v. drip for the first 10 days (0.6ug/kg/day)
Placebo
10 hours per day i.v. drip for the first 10 days (0ug/kg/day)
Beijing Chaoyang Hospital of Capital Medical University, Beijing
Beijing Friendship Hospital of Capital Medical University, Beijing
Chinese PLA General Hospital, Beijing
Fuwai hospital chinese Academy of Medical Sciences, Beijing
China-Japan Union Hospital of Jilin University, Changchun
The First Hospital of Jilin University, Changchun
The Second Xiangya Hospital of Central South University, Changsha
Chongqing University Three Gorges Hospital, Chongqing
The First Affiliated Hospital of Dalian Medical University, Dalian
First Affiliated Hospital,Sun Yat-sen University, Guangzhou
Guangdong Provincial People's Hospital, Guangzhou
Haikou People's Hospital, Haikou
Hainan General Hospital, Hainan
Hunan Provincial People's Hospital, Hunan
Jinan Central Hospital, Jinan
Qilu Hospital of Shandong University, Jinan
Shandong Province QianFoshan Hospital, Jinan
Luoyang Center Hospital, Luoyang
Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing
Shanghai First People's Hospital, Shanghai
Shanghai JiaoTong University Ruijing Hospital, Shanghai
Shanghai Putuo District Central Hospital, Shanghai
Shengjing Hospital of China Medical University, Shenyang
The First Affiliated Hospital of Soochow University, Suzhou
First Hospital of Shanxi Medical University, Taiyuan
Shanxi Cardiovascular Hospital, Taiyuan
People's Hospital of Tianjin, Tianjin
The Second Hospital of Tianjin Medical University, Tianjin
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Zensun Sci. & Tech. Co., Ltd.
INDUSTRY